809 An open randomized controlled study reported that urea-containing cream significantly decreased the incidence of HFSR in sorafenib-treated patients; 811 however, another randomized placebo-controlled trial failed to reach statistical significance. 812 2) Lenvatinib Lenvatinib is an oral multi-kinase inhibitor targeting VEGFR-1/2/3, fibroblast growth factor receptor (FGFR)-1/2/3/4, PDGFRα, RET, and C-kit.
← all excerpts
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.
1
—
—